Cart is empty Type 2 diabetes (T2D) accounts for more than 90% of the confirmed diabetes cases. It has become a common metabolic disease and is expected to affect 380 million people worldwide by 2025. Currently, clinically used diagnostic tests are mainly based on fasting plasma glucose, oral glucose tolerance test and glycosylated hemoglobin A1c (HbA1c). Although these methods are highly accurate, they are all invasive tests based on blood sampling.
Leave A Comment